Video Experimental Relacionado
Updated: Aug 19, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Hiperplasia suprarrenal congénita causada por la oxidorreductaza mutante P450 y la síntesis de andrógenos humanos:
Wiebke Arlt1, Elizabeth A Walker, Nicole Draper
1Division of Medical Sciences, Institute of Biomedical Research, Medical School, Birmingham B15 2TT, UK. w.arlt@bham.ac.uk
Lancet (London, England)
|June 29, 2004
Resumen
Las mutaciones en el gen P450 oxidoreductasa causan una forma rara de hiperplasia suprarrenal congénita, que conduce a genitales ambiguos y desequilibrios hormonales. Este descubrimiento revela una nueva vía en la síntesis fetal de andrógenos.
Área de la Ciencia:
- Endocrinología Endocrinología.
- Genética La genética.
- La bioquímica es la bioquímica.
Sus antecedentes:
- La hiperplasia suprarrenal congénita (HCA) con aparente deficiencia combinada de P450C17 y P450C21 se presenta con acumulación de metabolitos esteroideos, lo que sugiere una alteración de la actividad de la 17alfa-hidroxilasa y la 21-hidroxilasa.
- A pesar de los signos clínicos, las mutaciones en los genes CYP17 y CYP21 no se encuentran en los individuos afectados, dejando la base molecular desconocida.
- Las hembras afectadas presentan genitales ambiguos, bajos niveles de andrógenos circulantes y falta de virilización progresiva.
Videos de Conceptos Relacionados
01:21Smooth Endoplasmic Reticulum
Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...